Keyword: BioIndustry Association
AstraZeneca has signed on to be a founding partner for a new life sciences research hub in China, to be housed just west of Shanghai.
Perhaps nothing is more divisive in Britain today than Brexit. But what does it mean for R&D?
The BIA wants the government to “democratize” biotech investing by eliminating perceived barriers to more widespread participation in the sector.
The British biopharma industry is facing further uncertainty after last week’s general election left the country without a clear ruling party.
Two years out from the U.K.'s scheduled EU exit date, the life science sector is increasingly confident about its post-Brexit prospects.
As the British government looks to set out its economic plan for the coming months, biotech trade group the BIA has added what it sees as key policies that need to be strengthened as the country, and business, prepares for Brexit.